Ozempic, Wegovy introduced in Kenya as diabetes, obesity burden grows

The introduction of Ozempic and Wegovy in Kenya is drawing attention to the country’s growing cardio-metabolic health burden, as healthcare experts call for a more comprehensive approach to the prevention and management of type 2 diabetes, obesity and related conditions. The growing burden of diabetes, obesity and other cardio-metabolic conditions in Kenya is putting renewed focus on […] The post…